ClinVar Miner

Submissions for variant NM_002693.3(POLG):c.3708G>T (p.Gln1236His) (rs3087374)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 20
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genetic Services Laboratory, University of Chicago RCV000118022 SCV000152340 benign not specified 2013-08-29 criteria provided, single submitter clinical testing
PreventionGenetics,PreventionGenetics RCV000118022 SCV000309150 benign not specified criteria provided, single submitter clinical testing
Eurofins NTD LLC (GA) RCV000118022 SCV000340354 benign not specified 2016-03-16 criteria provided, single submitter clinical testing
Illumina Laboratory Services,Illumina RCV000291582 SCV000394244 likely benign Fanconi anemia 2016-06-14 criteria provided, single submitter clinical testing
Illumina Laboratory Services,Illumina RCV000327842 SCV000394245 benign POLG-Related Spectrum Disorders 2018-03-06 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Ambry Genetics RCV000715848 SCV000846679 benign Seizures 2016-03-15 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine RCV000758401 SCV000887086 benign Progressive sclerosing poliodystrophy 2018-10-01 criteria provided, single submitter clinical testing The NM_002693.2:c.3708G>T (NP_002684.1:p.Gln1236His) [GRCH38: NC_000015.10:g.89316763C>A] variant in FANCI gene is interpretated to be a Benign based on ACMG guidelines (PMID: 25741868). This variant meets the following evidence codes reported in the ACMG-guideline. BS1:The minor allele frequency of this allele is high for Mitochondrial DNA depletion syndrome 4A (Alpers type). BS2:Observation of the variant in controls is inconsistent with penetrance of Mitochondrial DNA depletion syndrome 4A (Alpers type). BP4:Computational evidence/predictors indicate no impact on the FANCI structure, function, or protein-protein interaction. Based on the evidence criteria codes applied, the variant is suggested to be Benign.
ARUP Laboratories, Molecular Genetics and Genomics,ARUP Laboratories RCV001000243 SCV001156794 benign Fanconi anemia, complementation group I 2021-09-08 criteria provided, single submitter clinical testing
Illumina Laboratory Services,Illumina RCV001000243 SCV001279799 benign Fanconi anemia, complementation group I 2018-03-06 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Athena Diagnostics Inc RCV000118022 SCV001474647 benign not specified 2020-03-02 criteria provided, single submitter clinical testing
Invitae RCV000758401 SCV001726587 benign Progressive sclerosing poliodystrophy 2020-12-04 criteria provided, single submitter clinical testing
Invitae RCV000291582 SCV001726588 benign Fanconi anemia 2020-12-04 criteria provided, single submitter clinical testing
GeneDx RCV000676315 SCV001934735 benign not provided 2015-03-03 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 31541998, 15917273, 21038416, 30255931)
GeneReviews RCV000020480 SCV000040917 benign Mitochondrial disease 2012-10-11 no assertion criteria provided curation Converted during submission to Benign.
Mayo Clinic Laboratories,Mayo Clinic RCV000676315 SCV000802073 benign not provided 2016-02-22 no assertion criteria provided clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000118022 SCV001743121 benign not specified no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, Amsterdam University Medical Center RCV000118022 SCV001808141 benign not specified no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV000118022 SCV001928243 benign not specified no assertion criteria provided clinical testing
Human Genetics - Radboudumc,Radboudumc RCV000118022 SCV001957867 benign not specified no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000118022 SCV001974279 benign not specified no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.